IDH1 and central nervous system cancer: Furthermore, we confirmed the role of IDH1 R132H mutations in affecting cellular redox status using glioma cell lines, and provided evidence to further explore the application of chemotherapy such as 5-FU in the treatment of gliomas with IDH1 R132H mutation.